Русский | English

ABOUT THE PREPARATION
News
Contacts

ABOUT THE PREPARATION
News
Contacts

Cytoprotective therapy for kidney injury in patients with ST-elevation myocardial infarction

Main > News > News archive > Cytoprotective therapy for kidney injury in patients with ST-elevation myocardial infarction

Cytoprotective therapy for kidney injury in patients with ST-elevation myocardial infarction

19.12.2017

|In News

|By karateeva

This article is in “Library” section.

Author:
N.YU. BOROVKOVA¹, A.S. ILYINA¹, A.A. SPASSKY², N.N. BOROVKOV¹, G.V. KOVALEVA³

MEXIDOL^®

Mexidol^® is an original (reference) domestic preparation with powerful anti-ischemic effect, a unique development of domestic pharmaceutical industry. Due to universal mechanism of action and a wide range of pharmacological effects Mexidol^® is effective in treatment of acute and chronic diseases, caused by ischemia and hypoxia of various genesis. To date, the drug is widely used in neurology, therapy, cardiology, psychiatry, and narcology.

Company “Pharmasoft”

109544, Moscow,
Boulevard of Enthusiasts, 2

+7 (495) 625-47-55
pharmasoft@pharmasoft.ru

www.pharmasoft.ru

Dear user!

This website is intended exclusively for health professionals.

Please confirm that you are a health professional:

YES, I AM NO, I AM NOT

Cytoprotective therapy for kidney injury in patients with ST-elevation myocardial infarction

MEXIDOL®

MEXIDOL^®